Paul J. Scheel III is a Cardiologist at Johns Hopkins Medicine in Baltimore, MD, USA, with expertise in Advanced Heart Failure and Transplant Cardiology. He is also an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. He obtained his M.D. degree from Washington University in St. Louis School of Medicine, where he was elected Alpha Omega Alpha. Then, he embarked on his training at Johns Hopkins Hospital. He completed his internship in Internal Medicine in 2017, followed by residency in Internal Medicine from 2017 to 2019. Driven by his passion regarding cardiovascular disease, he then pursued a fellowship in Cardiovascular Disease from 2019 to 2022. Building upon this foundation, he continued his training with a fellowship in Advanced Heart Failure and Transplant Cardiology, further honing his expertise in managing complex heart failure cases. He has been involved in research within the Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Left Ventricular Assist Device (LVAD) Programs at Johns Hopkins and has a wider interest in genetic cardiomyopathies and durable mechanical support.
Paul J. Scheel III is a Cardiologist at Johns Hopkins Medicine in Baltimore, MD, USA, with expertise in Advanced Heart Failure and Transplant Cardiology. He is also an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. He obtained his M.D. degree from Washington University in St. Louis School of Medicine, where he was elected Alpha Omega Alpha. Then, he embarked on his training at Johns Hopkins Hospital. He completed his internship in Internal Medicine in 2017, followed by residency in Internal Medicine from 2017 to 2019. Driven by his passion regarding cardiovascular disease, he then pursued a fellowship in Cardiovascular Disease from 2019 to 2022. Building upon this foundation, he continued his training with a fellowship in Advanced Heart Failure and Transplant Cardiology, further honing his expertise in managing complex heart failure cases. He has been involved in research within the Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Left Ventricular Assist Device (LVAD) Programs at Johns Hopkins and has a wider interest in genetic cardiomyopathies and durable mechanical support.